Morgan Stanley’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.5M Sell
2,735,644
-778,583
-22% -$2.46M ﹤0.01% 3815
2025
Q4
$13M Sell
3,514,227
-541,399
-13% -$1.75M ﹤0.01% 3364
2025
Q3
$10.7M Buy
4,055,626
+3,000,138
+284% +$5.8M ﹤0.01% 3475
2025
Q2
$1.04M Sell
1,055,488
-5,531,144
-84% -$5.54M ﹤0.01% 5075
2025
Q1
$9.48M Buy
6,586,632
+277,255
+4% +$511K ﹤0.01% 3385
2024
Q4
$13.9M Buy
6,309,377
+3,663,178
+138% +$8.55M ﹤0.01% 3093
2024
Q3
$4.37M Sell
2,646,199
-682,655
-21% -$1.38M ﹤0.01% 4059
2024
Q2
$7.39M Buy
3,328,854
+1,686,494
+103% +$3.97M ﹤0.01% 3565
2024
Q1
$4.4M Sell
1,642,360
-567,640
-26% -$1.38M ﹤0.01% 4015
2023
Q4
$6.61M Buy
2,210,000
+106,220
+5% +$138K ﹤0.01% 4210
2023
Q3
$2.06M Buy
2,103,780
+1,138,359
+118% +$1.65M ﹤0.01% 4374
2023
Q2
$1.34M Sell
965,421
-453,601
-32% -$633K ﹤0.01% 4654
2023
Q1
$2.26M Sell
1,419,022
-367,201
-21% -$1.9M ﹤0.01% 4383
2022
Q4
$11.1M Buy
1,786,223
+776,442
+77% +$5.55M ﹤0.01% 2974
2022
Q3
$6.77M Buy
1,009,781
+215,070
+27% +$1.48M ﹤0.01% 3389
2022
Q2
$5.05M Buy
794,711
+423,720
+114% +$2.4M ﹤0.01% 3753
2022
Q1
$1.72M Sell
370,991
-74,221
-17% -$318K ﹤0.01% 4629
2021
Q4
$2.23M Sell
445,212
-6,612
-1% -$52.9K ﹤0.01% 4499
2021
Q3
$5.44M Buy
451,824
+65,309
+17% +$951K ﹤0.01% 3594
2021
Q2
$8.18M Buy
386,515
+278,813
+259% +$6.71M ﹤0.01% 3230
2021
Q1
$3.02M Sell
107,702
-127,709
-54% -$3.77M ﹤0.01% 3919
2020
Q4
$6.12M Buy
235,411
+200,573
+576% +$6.01M ﹤0.01% 3040
2020
Q3
$1.29M Sell
34,838
-14,901
-30% -$590K ﹤0.01% 4021
2020
Q2
$2.55M Buy
49,739
+29,857
+150% +$1.25M ﹤0.01% 3360
2020
Q1
$627K Sell
19,882
-39,169
-66% -$2.07M ﹤0.01% 4251
2019
Q4
$3.52M Buy
59,051
+38,275
+184% +$1.72M ﹤0.01% 3569
2019
Q3
$761K Sell
20,776
-65,777
-76% -$2.61M ﹤0.01% 4460
2019
Q2
$4.03M Buy
86,553
+29,629
+52% +$1.39M ﹤0.01% 3137
2019
Q1
$2.29M Sell
56,924
-139,966
-71% -$6.28M ﹤0.01% 3477
2018
Q4
$9.06M Buy
196,890
+125,190
+175% +$6.03M ﹤0.01% 2235
2018
Q3
$3.18M Sell
71,700
-7,323
-9% -$336K ﹤0.01% 3628
2018
Q2
$3.1M Buy
79,023
+9,765
+14% +$493K ﹤0.01% 3666
2018
Q1
$5.01M Sell
69,258
-12,416
-15% -$912K ﹤0.01% 3023
2017
Q4
$5.38M Buy
81,674
+48,462
+146% +$2.61M ﹤0.01% 3043
2017
Q3
$1.66M Sell
33,212
-11,129
-25% -$537K ﹤0.01% 4046
2017
Q2
$2.05M Sell
44,341
-33,198
-43% -$1.22M ﹤0.01% 3766
2017
Q1
$2.74M Sell
77,539
-2,547
-3% -$58.3K ﹤0.01% 3517
2016
Q4
$1M Buy
80,086
+30,984
+63% +$369K ﹤0.01% 4460
2016
Q3
$680K Sell
49,102
-77,428
-61% -$878K ﹤0.01% 4316
2016
Q2
$1.25M Buy
126,530
+99,848
+374% +$1.65M ﹤0.01% 3808
2016
Q1
$452K Sell
26,682
-4,907
-16% -$78.9K ﹤0.01% 4507
2015
Q4
$704K Sell
31,589
-3,935
-11% -$99.3K ﹤0.01% 4304
2015
Q3
$837K Sell
35,524
-44,311
-56% -$2.78M ﹤0.01% 4259
2015
Q2
$6.53M Buy
79,835
+27,864
+54% +$2.73M ﹤0.01% 2555
2015
Q1
$4.81M Sell
51,971
-48,013
-48% -$3.1M ﹤0.01% 2792
2014
Q4
$4.04M Sell
99,984
-42,965
-30% -$1.32M ﹤0.01% 2929
2014
Q3
$3.5M Sell
142,949
-14,425
-9% -$229K ﹤0.01% 2955
2014
Q2
$2.49M Sell
157,374
-10,110
-6% -$146K ﹤0.01% 3304
2014
Q1
$2.53M Buy
167,484
+124,351
+288% +$1.93M ﹤0.01% 3218
2013
Q4
$593K Sell
43,133
-149,408
-78% -$2.17M ﹤0.01% 4320
2013
Q3
$3.63M Buy
+192,541
New +$3.23M ﹤0.01% 2733

Other funds holding ESPR